Both repaglinide and nateglinide belong to a class of glinides, which are Su-like agents that stimulate insulin secretion but are rapidly absorbed, with a short duration of action, thus contributing to reducing postprandial hyperglycemia. The gene discussed is INS; the disease is Hyperglycemia.